Corporate presentation
and factsheet

Corporate Management

Board of Directors

Corporate governance

Corporate social responsibility

Videos about Zealand

Product pipeline

Orphan drug designation

Glepaglutide (SBS)

Dasiglucagon (rescue)

Dasiglucagon (pump)

Dasiglucagon (CHI)

GLP-1/glucagon dual-acting agonist

Long-acting amylin analog

What are peptides?

Scientific Advisory Board

Investor relations

Stock information

Shareholder portal

Financial calendar

Financial reports

Annual General Meeting

Conference calls

Analyst Coverage

Zealand as a workplace

Unsolicited applications

Personal data in the recruitment process

Corporate presentation
and factsheet

Corporate Management

Board of Directors

Corporate governance

Corporate social responsibility

Videos about Zealand

Product pipeline

Orphan drug designation

Glepaglutide (SBS)

Dasiglucagon (rescue)

Dasiglucagon (pump)

Dasiglucagon (CHI)

GLP-1/glucagon dual-acting agonist

Long-acting amylin analog

What are peptides?

Scientific Advisory Board

Investor relations

Stock information

Shareholder portal

Financial calendar

Financial reports

Annual General Meeting

Conference calls

Analyst Coverage

Zealand as a workplace

Unsolicited applications

Personal data in the recruitment process

Media
Zealand news
Media inquiry
Downloads

Contact information

Lani Pollworth Morvan
Investor Relations and Communications
Phone: +45 50 60 37 78

lpm@zealandpharma.com

Zealand Pharma A/S Smedeland 36 2600 Glostrup Denmark Tel +45 88 77 36 00 info@zealandpharma.com

Legal disclaimer Privacy policy